top of page
ETC Still.jpg

How Erchonia® Low Level Laser Therapy Works.

GVL - NEW RELEASE!

The Newest Addition to Erchonia's

Hand-held Series is Here!

The First & ONLY FDA Cleared

Green & Violet Laser in the World

 

We are proud and excited to bring you the latest advancement in laser technology through rigorous clinical research and engineering. The green & violet combo has profoundly impacted the potential of laser therapy, and we can't wait to hear how this laser changes your practice and your patient's lives! 

The green & violet combo targets the mitochondria electron transport chain complexes 1, 2 & 3.

Indications for Use: – K221987
The Erchonia@ GVL laser is generally indicated:
a. while using the green and violet diode simultaneously, for adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin,
b. and while using the violet diode, to treat dermatological conditions, and specifically indicated to treat moderate
inflammatory Acne Vulgaris.

*Device intended for Medical Professionals
*Prescription Use (Part 21 CFR 801 Subpart D)

GVL_OEM_Cradle v1.png
XLR8_OEM_Cradle XLR8.png

XLR8 - Entry Level

The XLR8 laser is the ideal choice for chiropractors, doctors, physical therapists and other professionals who are looking to add laser therapy into their practice. The XLR8 has dual red lasers and has been proven through double-blind, multi-site, placebo-controlled clinical trials. It has been the work horse for medical professionals for 20+ years! With 22 total FDA clearances, no laser manufacturer is more trusted than Erchonia®.

The dual red combo targets the mitochondria

electron transport chain complex 4.

Indications for Use: – K211186
a. as adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin

b. as an adjunct to liposuction procedures of the thighs, hips, and stomach for reduction of pain associated with the recovery process

c. for the temporary reduction in post-surgery pain at 24 after surgery following bilateral breast augmentation surgery

d. as an adjunctive treatment of postoperative pain

*Device intended for Medical Professionals
*Prescription Use (Part 21 CFR 801 Subpart D)

EVRL - Most Popular

Erchonia’s red & violet handheld laser, the EVRL. Since its release has become our most popular handheld device by offering the versatility of a red and violet wavelength taking outcomes to a whole new level. By combining these two specific wavelengths into one treatment modality, patients received better results during clinical studies then the dual red and opened up a new range of treatment conditions stimulating complexes 1, 2 & 4! The violet is also shown to be effective with its anti-bacterial & anti-microbial properties.

The exceptional versatility of this violet and red laser pain treatment allows doctors, chiropractors, physical therapists and other medical professionals to target a broader range of conditions with a single, easy-to-use device. With exceptional clinical research and FDA market clearance in treating chronic conditions.

The red & violet targets the mitochondria electron transport chain complexes 1, 2 & 4.

Indications for Use: – K152196
The Erchonia® EVRL laser is generally indicated:
a. while using the red diode, for adjunctive use in providing temporary relief of minor chronic neck and shoulder pain of musculoskeletal origin,
b. and while using the violet diode, to treat dermatological conditions, and specifically indicated to treat moderate inflammatory Acne Vulgaris.

*Device intended for Medical Professionals
*Prescription Use (Part 21 CFR 801 Subpart D)

EVRL_OEM_Cradle v1.png
GVL_BST_.png

Base Station - Deluxe

The Base Station is a desk top unit with three (3) independent handheld laser devices including any combination of our 3 handhelds. The default option would be (1) EVRL, (1) XLR8 laser & (1) GVL laser. This also includes a wireless charging station and the ability to program all of the lasers individually. Physicians are able to use innovative laser therapy in 3 locations at once with this platform whether that be in separate offices or to rent out to patients. Fully impact the ETC with red, green & violet. 

Stimulates ALL complexes!

Comparison Charts

LED VS LASER

Erchonia uses LEDs as the placebo treatment for our clinical research.

5 Double Blind Studies (419 Subjects)

Study VS LEDs 2.png

Reduction in Pain
Laser Group: 45.5% | LED Group: 15%

Study VS LEDs 3.png

Reduction in Pain
Laser Group: 62% | LED Group: 14%

What Erchonia Laser is Right For Me?

bottom of page